<html>
<head>
<title>How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">大脑和大脑神经科学如何开展抑郁症的家庭临床试验 TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2021/12/20/how-cerebral-and-alto-neuroscience-embarked-on-an-at-home-clinical-trial-for-depression/amp/">https://web.archive.org/web/https://techcrunch.com/2021/12/20/how-cerebral-and-alto-neuroscience-embarked-on-an-at-home-clinical-trial-for-depression/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg 5000w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=150,98 150w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=300,195 300w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=768,499 768w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=680,442 680w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=1536,998 1536w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=2048,1331 2048w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=1200,780 1200w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=50,33 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/9239619e238136c4e52fab67da717946.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg 5000w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=150,98 150w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=300,195 300w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=768,499 768w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=680,442 680w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=1536,998 1536w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=2048,1331 2048w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=1200,780 1200w, https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?resize=50,33 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20221104021926im_/https://techcrunch.com/wp-content/uploads/2021/12/GettyImages-1319228438.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong>叶夫根尼·格罗莫夫/盖蒂图片社</p><p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">在疫情将远程工作、学校和研究推向前沿之前，分散的临床试验可能即将出现。现在，他们真的来了。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">本周，精准精神病学初创公司 Alto Neuroscience 和在线精神健康提供商 brain 宣布，他们已经联手为 Alto Neuroscience 的抑郁症候选药物 ALTO-300 进行分散式<a href="https://web.archive.org/web/20221104021926/https://www.clinicaltrials.gov/ct2/show/NCT05157945?term=Alto+Neuroscience&amp;draw=2&amp;rank=3" target="_blank" rel="noopener">2 期临床试验</a>。这项研究将主要在患者家中进行。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">具体来说，该项目将从大脑平台招募大约 200 名志愿者，他们目前正在与抑郁症作斗争，并且没有看到现有治疗的任何好处。除了提供新药，Alto Neuroscience 还将验证其药物开发方法:使用患者生物标志物来预测患者会(或不会)对哪些药物产生反应。</span></p>
<p class="translated">“在花费 10 亿美元进行临床试验之前，你会对患者群体进行深入的表型分析，并找出哪些患者群体真正受益于该药物，这种想法在世界上很有意义，但没有人这样做，”大脑首席医疗官 David Mou 告诉 TechCrunch。</p>
<p class="translated">从某种意义上说，这是天造地设的一对。我们有他们需要的东西，我相信他们的愿景将是最可行的。”</p>
<h2 class="translated">分散临床试验有什么有趣的地方？</h2>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“分散临床试验”的定义</span> <a href="https://web.archive.org/web/20221104021926/https://www.researchgate.net/profile/Andrea-Coravos/publication/332599045_Decentralized_Trials_in_the_Age_of_Real-World_Evidence_and_Inclusivity_in_Clinical_Investigations/links/5f2748c992851cd302d57189/Decentralized-Trials-in-the-Age-of-Real-World-Evidence-and-Inclusivity-in-Clinical-Investigations.pdf" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">略有不同</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">，但从本质上来说，它意味着以某种形式为患者提供护理，无论是通过虚拟方式还是通过移动临床医生。数据通常也是在患者所在地收集，而不是通过定期访问研究中心。</span></p>
<p class="translated">将临床试验带给患者确实有可能解决临床试验目前面临的主要问题，因为这一过程对患者来说不那么繁琐。近 <a href="https://web.archive.org/web/20221104021926/https://www.nationalacademies.org/news/2019/08/virtual-clinical-trials-a-new-model-for-patient-engagement#:~:text=Nearly%2070%20percent%20of%20potential,visits%20is%20not%20an%20option." target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">例如，70%的临床试验参与者</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">住在离研究中心两小时以上的地方。招募也是试验被终止的常见原因，据估计</span> <a href="https://web.archive.org/web/20221104021926/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342339/" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> 80%的临床试验</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">不能按时招募患者。最后，专家建议将试验带给患者</span> <a href="https://web.archive.org/web/20221104021926/https://www.nationalacademies.org/news/2019/08/virtual-clinical-trials-a-new-model-for-patient-engagement#:~:text=Nearly%2070%20percent%20of%20potential,visits%20is%20not%20an%20option." target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">可能有助于</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">提高药物研究的多样性和可及性。</span></p>
<p class="translated">这项试验远非有史以来第一次分散的临床试验，但它确实发生在该领域的一个转折点。</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">在疫情之前，只有 38%的制药和合同研究组织(cro)</span><a href="https://web.archive.org/web/20221104021926/https://www.mckinsey.com/industries/life-sciences/our-insights/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials" target="_blank" rel="noopener"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">告诉麦肯锡</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">分散临床试验将是他们投资组合的主要部分。</span></p>
<p class="translated">当麦肯锡在 2020 年再次调查这些相同的组织时，100%的人预计分散式试验将发挥巨大作用。</p>
<h2 class="translated">这场审判能告诉我们什么</h2>
<p class="translated">这项试验有可能揭示很多关于在家收集的数据的强度，FDA 对这些数据的态度，以及分散临床试验是否真的解决了现场试验在现实生活中面临的问题。</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">收集深入的数据对于 Alto Neuroscience 的药物开发策略尤为重要。这是因为该公司基于开发独特的、由生物标志物驱动的精神健康诊断患者画像，从脑电图测量到情绪和情感问卷。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“我们正在开发针对各种精神疾病的新药，重点是利用大脑测试或大脑生物标志物来确定谁是正确的患者，”Alto Neuroscience 的创始人兼首席执行官 Amit Etkin 告诉 TechCrunch。</span></p>
<p class="translated">“在这种情况下，这意味着我们所做的一切的核心部分是试图确保我们的生物标志物以最概括的方式识别出对我们的药物有反应的患者。”</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">大脑成为 Alto Neuroscience 即将进行的试验的一个有吸引力的合作伙伴有几个原因。首先，该公司能够迅速找到符合临床试验具体条件的人群:“我们在一小时内撤出了这 200 名患者，”牟说。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">但关键的一点是，大脑已经收集了大量关于患者及其临床医生的数据——这表明他们有能力收集 Alto 神经科学所需的高质量数据。这包括患有严重抑郁症的患者的数据(属于健康类别的应用程序通常不提供这一类别)。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">例如，大脑病人已经定期填写关于症状和情绪的问卷。该公司还拥有医生处方模式的数据，这可以让我们深入了解什么有效，什么无效。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“因为我们如此专注于高质量的护理，这迫使我们在后端创建一个数据基础设施，以便比现有的任何其他心理健康服务提供商更好地了解我们的患者和临床医生，”牟说。</span></p>
<p class="translated">一个挥之不去的问题是，FDA 将如何看待以分散、甚至远程的方式收集的数据。这个过程还在发展中。<a href="https://web.archive.org/web/20221104021926/https://www.fda.gov/about-fda/oncology-center-excellence/advancing-oncology-decentralized-trials" target="_blank" rel="noopener"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">4 月</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">例如，该机构要求肿瘤学分散试验对其数据集进行标记，以区分哪些数据是亲自收集的，哪些是远程收集的。</span></p>
<p class="translated">这次试验可能会提供一个很好的比较点。Alto Neuroscience 目前实际上正在运行 <i> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">两个</span> </i> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">类似的临床试验，在 ALTO-300 上:</span> <a href="https://web.archive.org/web/20221104021926/https://clinicaltrials.gov/ct2/show/NCT05157945?term=Alto+Neuroscience&amp;draw=2&amp;rank=3" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">一个与大脑</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">和</span> <a href="https://web.archive.org/web/20221104021926/https://clinicaltrials.gov/ct2/show/NCT05118750?term=Alto+Neuroscience&amp;draw=2&amp;rank=4" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">另一个以传统的场地形式</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">。</span></p>
<p class="translated">艾特金说，这里的策略不仅仅是评估 ALTO-300 的有效性。它测试了分散精确精神病学临床试验的整个概念。</p>
<p class="translated">“我们试图做的一部分也是验证我们为 FDA 所采用的方法，这样我们就可以证明我们在分散式方法中得到的与基于站点的方法中得到的是等效的，”Etkin 说。</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">最后，有证据表明，这项试验克服了与传统临床试验相关的障碍，比如招募问题。但它并不完美。例如，大脑试验中的患者仍然住在纽约、达拉斯或亚特兰大，而不是住在离主要医疗中心几小时路程的地方。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“是否解决了表象的问题？“不完全是，”牟指出。“但我要说的是，这是一个忠诚度更高的群体:他们患真正抑郁症的几率比以传统方式出去，通过实体诊所招募患者要高得多。”</span></p>
<h2 class="translated">从试验到商业化</h2>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">两位创始人都指出，分散试验也可以为药物商业化铺平道路。</span> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">例如，牟指出，大脑可以很容易地帮助将药物部署到批准后可能受益的患者身上。</span></p>
<p class="translated">从 Alto Neuroscience 的角度来看，大脑可以成为帮助将精神健康生物标志物引入临床实践的渠道——这是诊断精神健康状况的一个长期问题。(历史上，精神健康诊断是通过观察行为症状而不是医学测试来做出的。尽管一些研究人员和商业公司如 Alto Neuroscience 一直在寻求 <a href="https://web.archive.org/web/20221104021926/https://www.axios.com/mental-disorders-precision-psychiatry-ddd2f6b2-9f93-4854-9ef7-f52bf82e6068.html" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">将该领域</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">转向基于有效生物标志物的诊断。)</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“像大脑这样的合作伙伴将是将我们的生物标记物(一旦获得批准)用于临床实践的理想选择，因为他们的临床护理是如此结构化和跟踪良好。”</span></p>
<p class="translated">至于目前的这项试验，两家公司预计将在 2022 年底获得首次读数。</p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20221104021926im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
		<amp-pixel src="https://web.archive.org/web/20221104021926im_/https://pixel.wp.com/g.gif?v=ext&amp;j=1%3A11.4&amp;blog=136296444&amp;post=2249444&amp;tz=-7&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
	<amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>